Mesenteric Lymph Node Metastasis and Nutritional Status After Bowel Resection for Ovarian Cancer

计划入组 300 人 · 首次发布于 2024 年 7 月 30 日

Efficacy of Postoperative Radiotherapy for Atypical Meningioma Without Venous Sinus Invasion After Gross-total Resection

计划入组 140 人 · 首次发布于 2019 年 10 月 16 日

Impact of Chemotherapy Dose Reductions on Survival Outcomes Among Older NSCLC Patients Without Actionable Mutations

计划入组 150 人 · 首次发布于 2026 年 1 月 27 日

Tiragolumab

ARK5 inhibitors (tumor progression)

K201 free base

C₂₅H₃₂N₂O₂S

Shanghai Yizhong Pharmaceutical Co., Ltd.

THOMPSON CANCER SURVIVAL CENTER

United States

Free University of Brussels

LEAP-012 Trial: Lenvatinib, Pembrolizumab, and TACE Improve PFS in Intermediate-Stage HCC

Pazopanib and Bevacizumab Combination Doubles Progression-Free Survival in Metastatic Kidney Cancer

TACE Plus Camrelizumab and Rivoceranib Improves PFS in Unresectable HCC